BioSpace News Archive

Business

Relief Therapeutics and NeuroRx Release Promising Data for Potential COVID-19 Treatment Aviptadil

Relief Therapeutics and NeuroRx released results on Tuesday from their open-label prospective study looking into RLF-100 (aviptadil) as a potential treatment for COVID-19 and respiratory failure.

October 14, 2020
·
3 min read
·
Krystle Vermes
BioCapital

Wasp Venom Shows Potential Against Antibiotic-Resistant Bacteria

Scientists hope to use powerful antimicrobial molecules found in the wasp venom against the antibiotic-resistant bacteria that cause sepsis and tuberculosis.

October 14, 2020
·
2 min read
·
Heather McKenzie
Drug Development

Pros and Cons of the Common Types of COVID-19 Tests

While COVID-19 tests have been crucial in identifying and tracking cases of infection and disease-related morbidity and mortality, they aren’t without their potential drawbacks.

October 14, 2020
·
5 min read
·
Brandon May
Aimmune Becomes Point Pharmaceutical Business for Nestlé

In August, Nestlé gobbled up Aimmune in a $2.6 billion deal, and now the food allergy-focused company will serve as the point pharmaceutical business for Nestlé Health Science.

October 14, 2020
·
2 min read
·
Alex Keown
Business

Pfizer Gets FDA OK to Test Adolescents in COVID-19 Vaccine Trial

To date, all the major clinical trials of vaccines against COVID-19 have been in adults.

October 14, 2020
·
3 min read
·
Mark Terry
BioSpace Global Roundup, Oct. 15

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

October 14, 2020
·
8 min read
·
Alex Keown
Policy

CDC Finalizes COVID-19 Vaccine Distribution Plan as Vaccine Authorization Nears

With multiple COVID-19 vaccines in development, the CDC is confident that any vaccines the FDA authorizes or approves will be safe because they are based on the FDA’s usual stringent protocols. The greater question, after a vaccine is approved, is how it will be distributed.

October 14, 2020
·
4 min read
·
Gail Dutton
Career Advice

4 Things to Make Sure You Don’t Include on Your Resume

When a recruiter or hiring manager is scanning it, you want them to be able to immediately understand your strengths, experiences and why you’re the right fit for the open position.

October 14, 2020
·
2 min read
·
Laura Brothers
Drug Development

Cyclerion Presents Bad News in Sickle Cell Study, Good News in CNS Trial

Cyclerion is a clinical-stage biopharmaceutical company developing treatments for serious and orphan diseases affecting the central nervous system (CNS).

October 14, 2020
·
3 min read
·
Heather McKenzie
Pharm Country

Canaan Closes $800 Million VC Fund for Life Sciences and Technology

Venture capital firm Canaan Partners closed on a new fund, it’s twelfth, raising $800 million to invest.

October 14, 2020
·
3 min read
·
Mark Terry